ISRCTN10763234 : Evaluation of antibody persistence in Ghanaian children more than five years after vaccination with MenAfriVac® widely used in Sub-Saharan Africa to prevent epidemic Meningitis
- Overall trial status
- Completed
- Recruitment status
- No longer recruiting
Ghana
Nervous System Diseases